RAN-CITALO
RANBAXY PHARMACEUTICALS CANADA INC.
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is RAN-CITALO discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that RAN-CITALO 20MG has been permanently discontinued (last updated March 7, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is RAN-CITALO not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ESCITALOPRAM
SIVEM PHARMACEUTICALS ULC
M-ESCITALOPRAM
MANTRA PHARMA INC
NOVO-CITALOPRAM
NOVOPHARM LIMITED
CITALOPRAM
MYLAN PHARMACEUTICALS ULC
Other Products
CELEXA 40 MG
LUNDBECK CANADA INC
RIVA-ESCITALOPRAM
LABORATOIRE RIVA INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02285622
Strength
20MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Other Products from RANBAXY PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02285630
12MCG · DIN 02330105
75MCG · DIN 02330148
25MCG · DIN 02330113
50MCG · DIN 02330121
100MCG · DIN 02330156
100MG · DIN 02319055
400MG · DIN 02319071
10MG · DIN 02421364
850MG · DIN 02269058
500MG · DIN 02269031
1MG · DIN 02358093